Probably Genetic

Provides free at-home genetic testing services

San Francisco, California, United States

About Probably Genetic

Probably Genetic provides genetic testing services specifically for individuals with rare diseases. Their main offering is a free at-home genetic testing kit, which allows patients to collect DNA samples in a convenient manner. After the samples are sent back to the company, they are analyzed to help patients receive accurate diagnoses and genetic counseling. Unlike many competitors, Probably Genetic operates its program at no cost to eligible patients by funding it themselves and managing all data collected. This data, once de-identified, can be shared with research institutions and pharmaceutical companies, creating a revenue stream for the company. The goal of Probably Genetic is to assist rare disease patients in obtaining timely diagnoses while also contributing to research in the field of rare diseases.

San Francisco, CaliforniaHeadquarters
2019Year Founded
$10.6MTotal Funding
EARLY_VCCompany Stage
Biotechnology, HealthcareIndustries
11-50Employees

Benefits

Unlimited Paid Time Off
Hybrid Work Options
Remote Work Options
Company Equity
Health Insurance
Dental Insurance
Parental Leave

Risks

Increased competition from new genetic testing startups threatens market share.
Reliance on data aggregation for revenue may face privacy regulation challenges.
Free test model may become unsustainable if funding diminishes or costs rise.

Differentiation

Probably Genetic offers free at-home genetic testing for rare diseases.
The company partners with foundations to enhance access to genetic testing.
They provide a comprehensive clinical genetic report with physician review and counseling.

Upsides

Partnerships with foundations expand reach and credibility in the rare disease community.
Growing interest in health tech startups may lead to more funding opportunities.
Rising demand for at-home testing aligns with their business model.

Funding

Total raised$10.60 M
Latest valuation$53.50 M
StageEARLY_VC
EARLY VC
10/31/2023
$11
$53.50 M
N/A
$1.00 M